Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
39.16
-1.61 (-3.95%)
At close: Dec 5, 2025, 4:00 PM EST
38.50
-0.66 (-1.70%)
After-hours: Dec 5, 2025, 7:35 PM EST
Phibro Animal Health Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Phibro Animal Health stock have an average target of 31.25, with a low estimate of 22 and a high estimate of 50. The average target predicts a decrease of -20.20% from the current stock price of 39.16.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Phibro Animal Health stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $45 → $50 | Buy | Maintains | $45 → $50 | +27.68% | Nov 7, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $19 → $27 | Sell | Maintains | $19 → $27 | -31.05% | Aug 29, 2025 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades $25 → $35 | Hold → Buy | Upgrades | $25 → $35 | -10.62% | Jul 7, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $21 → $26 | Hold | Maintains | $21 → $26 | -33.61% | Jun 25, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $20 → $21 | Hold | Maintains | $20 → $21 | -46.37% | May 8, 2025 |
Financial Forecast
Revenue This Year
1.50B
from 1.30B
Increased by 15.34%
Revenue Next Year
1.54B
from 1.50B
Increased by 3.28%
EPS This Year
2.79
from 1.19
Increased by 134.86%
EPS Next Year
3.08
from 2.79
Increased by 10.13%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.6B | 1.6B | |
| Avg | 1.5B | 1.5B | |
| Low | 1.4B | 1.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 19.7% | 7.0% | |
| Avg | 15.3% | 3.3% | |
| Low | 10.0% | -2.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.94 | 3.23 | |
| Avg | 2.79 | 3.08 | |
| Low | 2.61 | 2.85 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 147.1% | 15.7% | |
| Avg | 134.9% | 10.1% | |
| Low | 119.1% | 2.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.